CYP2B6 Induction Reporter Assay

Confirm delete?

CYP2B6 Induction Reporter Assay Kit

Zoom

Cat No: 600680

Assay Kits - Cell-Based Assays

Early screening of a drug candidate’s potential to induce or inhibit CYP2B6 is a critical step in the drug development process. Cayman's CYP2B6 Induction Reporter Assay Kit is a novel method to evaluate human Constitutive Androstane Receptor 3 (hCAR3)...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

kits cells CBAs cell-based assays measuring measurement cytochromes P450s CYP450s CYP-450 heme-thiolates monoxygenases metabolizes endogenous compounds xenobiotics pollutants environmental drugs enzymes metabolisms medications pharmacokinetics multiple doses dosing CYP 2B6 CYP-2B6 biotransformations clinically isozymes inducible genes transcriptional nuclear receptors constitutive androstane hCAR3-mediated hCAR 3 hCAR3 hCAR-3 human activation translocations splice splicing variants activators CITCO 6-(4-clorophenyl)imidazo[2,1-b]thiazole-5-carbaldehydeO-(3,4-dichlorobenzyl)oxime phenobarbital inhibits inhibitors inhibition toxicity low efficacy efficacies developments primary hepatocytes hepatocyte-like regulatory pathways cultured lines transfected construct promoter/enhancer sequences high-throughput hepatic inducers Surface Transfection and Expression Protocol solid phases transient transfection technology technologies Originus Inc Incorproated University of Michigan UofM U of M USPT US patents 6897067 6902933 7056741 native recombinant proteins adherent coatings receptor-mediated endocytosis DNA deoxyribonucleic acids complexes solution-phases co-transfection Secreted Alkaline Phosphatase SEAP promoters Hepatocyte Nuclear Factor-4a HNF-4a Factor-4.alpha. HNF-4.alpha. Factor-4alpha HNF-4alpha Factor-4? HNF-4? inducers inducer-activated factors signals signaling mediums luminescence-based alkaline phosphotase substrates screening screens reverse reporter assay

Product Overview:
Early screening of a drug candidate’s potential to induce or inhibit CYP2B6 is a critical step in the drug development process. Cayman's CYP2B6 Induction Reporter Assay Kit is a novel method to evaluate human Constitutive Androstane Receptor 3 (hCAR3)-mediated CYP2B6 induction for the discovery of hepatic CYP inducers. Our Reverse Transfection Reporter Assays have overcome many of the disadvantages of other transfection approaches. Cayman's CYP2B6 Induction Reporter Assay Kit consists of a 96-well plate coated with a transfection complex containing a Secreted Alkaline Phosphatase (SEAP) reporter regulated by the human CYP2B6 gene promoter. The complex also contains two nuclear receptor expression constructs, human Constitutive Androstane Receptor 3 (hCAR3) and human Hepatocyte Nuclear Factor 4α (HNF4α). Cells grown on the CYP2B6 Reverse Transfection Strip Plate will introduce the reporter gene and express CAR3 and HNF4α. Binding of inducer-activated receptor and transcription factors to the CYP2B6 promoter initiates a signal resulting in expression of SEAP, which is secreted into the cell culture medium. Aliquots of medium are removed at time intervals beginning at about 24 hours and SEAP activity is measured simply by adding a luminescence-based alkaline phosphatase substrate provided in the kit. The kit is simple to use and can be easily adapted to high-throughput screening for potential CAR-mediated CYP2B6 inducers. A known CYP2B6 inducer, CITCO, is included in the kit for use as a positive control.

Size	100 tests
Shipping	dry ice
Custom Code	3822.19
UNSPSC code	41116104

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.